Improving access to genetic testing for underserved cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of a computer-generated character providing genetic testing information to patients versus traditional information from human healthcare providers. It aims to enhance access to genetic counseling and testing, particularly for racial/ethnic minority patients and those in rural areas. The study involves multiple phases, including focus groups for feedback on the educational content, usability testing, and a pilot test to evaluate the new intervention. Patients will be randomized to receive either the new educational tool or standard care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years old
* Diagnosed with least one of the following:

  * Epithelial ovarian cancer
  * Exocrine pancreatic cancer
  * Metastatic or high or very high-risk prostate cancer
  * Breast cancer at or before age 50
  * Bilateral breast cancer
  * Triple negative breast cancer
  * Male breast cancer OR
  * Healthcare provider who treats patients with any of the above types of cancer
* Able to read and write in English or Spanish
* Able to provide informed consent

Exclusion Criteria:

* Patients who cannot provide informed consent
* Patients who cannot see, read, or write
* Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
* Patients with none of the listed cancer diagnoses and clinical characteristics
* Healthcare provider who do not treats cancer patients

Where it's running

• USC / Norris Comprehensive Cancer Center
  Los Angeles, California, United States Recruiting
• University of Rochester
  Rochester, New York, United States Recruiting

Study contacts

• Principal investigator: Charite Ricker, MS — University of Southern California
• Study coordinator: Charite Ricker, MS
• Email: ricker@usc.edu
• Phone: 323-409-7710

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Vanguard: a new blood test approach to screen for multiple cancers

  This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.

  Recruiting at 46 sites National Cancer Institute (NCI) · Pleasanton, California and 45 other locations · NCT06995898

• Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy

  This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.

  Recruiting Phase 2 Mayo Clinic · Scottsdale, Arizona · NCT06855524

• Hypofractionated radiotherapy for non-metastatic breast cancer treatment

  This study is testing if giving a shorter course of radiation therapy before or after surgery can help women with non-metastatic breast cancer while causing fewer severe side effects.

  Recruiting Phase 2 Mayo Clinic · Scottsdale, Arizona · NCT06635980

• Using cryocompression and cilostazol to prevent nerve damage from chemotherapy in women with gynecological cancers

  This study is testing if using cryocompression therapy alone or with a medication called cilostazol can help prevent nerve damage from chemotherapy in women with gynecological cancers.

  Recruiting Phase 2 Emory University · Atlanta, Georgia and 2 other locations · NCT06492070

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.